Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement.

Benhalima K, Durnwald C, Sweeting A, Adams D, Addala A, Battelino T, Bergenstal RM, Carlson A, Donovan LE, Reis Franco D, Heverly J, Isaacs D, Khunti K, Kihara AB, Levitt N, Levy CJ, Lewer M, Mathiesen E, Murphy HR, Nishimura R, Polsky S, Ram U, Simmons D, Yamamoto JM, Tabák ÁG, Feig D, Scott EM

Open source

DOI
10.1016/s2213-8587(25)00335-3
Published
2026 Feb
Container
The lancet. Diabetes & endocrinology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2213-8587-25-00335-3,
  title = {Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement.},
  author = {Benhalima K and Durnwald C and Sweeting A and Adams D and Addala A and Battelino T and Bergenstal RM and Carlson A and Donovan LE and Reis Franco D and Heverly J and Isaacs D and Khunti K and Kihara AB and Levitt N and Levy CJ and Lewer M and Mathiesen E and Murphy HR and Nishimura R and Polsky S and Ram U and Simmons D and Yamamoto JM and Tabák ÁG and Feig D and Scott EM},
  year = {2026},
  journal = {The lancet. Diabetes \& endocrinology},
  doi = {10.1016/s2213-8587(25)00335-3},
  url = {https://doi.org/10.1016/s2213-8587(25)00335-3}
}

RIS

TY  - JOUR
TI  - Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement.
AU  - Benhalima K
AU  - Durnwald C
AU  - Sweeting A
AU  - Adams D
AU  - Addala A
AU  - Battelino T
AU  - Bergenstal RM
AU  - Carlson A
AU  - Donovan LE
AU  - Reis Franco D
AU  - Heverly J
AU  - Isaacs D
AU  - Khunti K
AU  - Kihara AB
AU  - Levitt N
AU  - Levy CJ
AU  - Lewer M
AU  - Mathiesen E
AU  - Murphy HR
AU  - Nishimura R
AU  - Polsky S
AU  - Ram U
AU  - Simmons D
AU  - Yamamoto JM
AU  - Tabák ÁG
AU  - Feig D
AU  - Scott EM
PY  - 2026
JO  - The lancet. Diabetes & endocrinology
DO  - 10.1016/s2213-8587(25)00335-3
UR  - https://doi.org/10.1016/s2213-8587(25)00335-3
ER  - 

APA

K, B., C, D., A, S., D, A., A, A., T, B., RM, B., A, C., LE, D., D, R. F., J, H., D, I., K, K., AB, K., N, L., CJ, L., M, L., E, M., HR, M., R, N., S, P., U, R., D, S., JM, Y., ÁG, T., D, F., & EM, S. (2026). Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement.. The lancet. Diabetes & endocrinology. https://doi.org/10.1016/s2213-8587(25)00335-3

Source records